Skip to main content
. 2021 Mar 1;17(3):461–469. doi: 10.5664/jcsm.8934

Table 1.

Comparisons of demographic and polysomnographic characteristics between the iRBD and control groups.

Variable iRBD (n = 47) Control (n = 26) P Value
Age 67.17 ± 6.79 67.19 ± 6.41 .989
Sex (female) 19 (40.4%) 12 (46.2%) .805
TIB, min 480.93 ± 30.02 479.85 ± 23.96 .875
TST, min 385.24 ± 48.63 378.19 ± 63.31 .624
Sleep efficiency, % 80.47 ± 11.11 91.34 ± 69.04 .292
WASO, min 76.61 ± 51.69 91.44 ± 54.19 .252
Sleep latency, min 18.49 ± 22.86 11.62 ± 11.07 .154
R latency, min 125.61 ± 65.82 98.29 ± 53.61 .075
Stage N1, % 24.65 ± 13.81 19.58 ± 9.07 .097
Stage N2, % 52.15 ± 12.96 56.66 ± 7.63 .066
Stage N3, % 4.20 ± 5.77 3.77 ± 5.50 .755
Stage R, % 18.99 ± 7.76 20.00 ± 6.56 .579
AHI, events/h 6.89 ± 4.10 5.63 ± 3.72 .202
PLMI, events/h 26.79 ± 38.89 12.37 ± 19.65 .082
Hypertension 17 (36.2%) 6 (22.2%) .300
Coronary vascular disease 6 (12.8%) 2 (7.4%) .703

AHI = apnea-hypopnea index; iRBD = idiopathic rapid eye movement sleep behavior disorder, PLMI = periodic limb movement index, TIB = time in bed, TST = total sleep time, WASO = wake after sleep onset.